Studies have reported decreased ATP13A2 protein levels in the substantia nigra dopaminergic neurons and frontal cortex of PD patients compared to controls (Fujii et al., 2023, Kitada et al., 1998, Dehay et al., 2012). Here, ATP13A2 is linked to Parkinson disease.